JAK2 and lip and oral cavity carcinoma: And in IFN-γ-stimulated human oral cancer cells, p-JAK1 and p-JAK2 are inhibited by EGCG, and EGCG inhibits STAT1 translocation to the nucleus (Cheng et al., 2010).